| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
197,700,000 |
| Market
Cap: |
1.19(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0022 - $1.03 |
|
| Level
I Sector: |
Financials |
| Level
II Sector: |
Financial Services |
| Level
III Sector: |
Diversified Investments |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Athersys is a biotechnology company that is focused primarily in the field of regenerative medicine. Co.'s MultiStem® (invimestrocel) cell therapy, a patented and proprietary allogeneic stem cell product, is its primary platform product and is in late-stage clinical development. By applying its proprietary MultiStem cell therapy product, Co. provides therapeutic product development programs treating neurological conditions, inflammatory and immune disorders, certain pulmonary conditions, cardiovascular disease and other conditions. Co.'s primary programs are focused in the critical care area, with treatment provided in hospitals often in intensive care situations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
100,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$54,960 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Van Bokkelen Gil |
Chmn & Chief Executive Officer |
• • – |
2008-12-03 |
4 |
B |
$0.35 |
$4,375 |
D/D |
12,500 |
165,032 |
2.73 |
- |
|
| Van Bokkelen Gil |
Chmn & Chief Executive Officer |
• • – |
2008-12-02 |
4 |
B |
$0.35 |
$4,375 |
D/D |
12,500 |
152,532 |
2.73 |
- |
|
| Van Bokkelen Gil |
Chmn & Chief Executive Officer |
• • – |
2008-11-28 |
4 |
B |
$0.40 |
$9,814 |
D/D |
22,500 |
140,032 |
2.81 |
- |
|
| Harrington John J |
Dir. & Chief Scientific Off. |
• • – |
2008-11-24 |
4 |
B |
$0.33 |
$1,650 |
D/D |
5,000 |
96,644 |
2.73 |
- |
|
| Van Bokkelen Gil |
Chmn & Chief Executive Officer |
• • – |
2008-11-24 |
4 |
B |
$0.33 |
$4,125 |
D/D |
12,500 |
117,532 |
2.73 |
- |
|
| Harrington John J |
Dir. & Chief Scientific Off. |
• • – |
2008-11-21 |
4 |
B |
$0.33 |
$1,926 |
D/D |
5,835 |
91,644 |
2.73 |
- |
|
| Sheffery Michael B |
Director |
– • – |
2008-05-22 |
4 |
B |
$2.40 |
$643,200 |
I/I |
268,000 |
3,448,000 |
2.1 |
- |
|
| Isaly Samuel D |
Director |
– • • |
2008-05-22 |
4 |
B |
$2.40 |
$643,200 |
I/I |
268,000 |
3,448,000 |
2.25 |
- |
|
| Sheffery Michael B |
Director |
– • – |
2008-05-21 |
4 |
B |
$2.40 |
$312,000 |
I/I |
130,000 |
3,180,000 |
2.1 |
- |
|
| Isaly Samuel D |
Director |
– • • |
2008-05-21 |
4 |
B |
$2.40 |
$312,000 |
I/I |
130,000 |
3,180,000 |
2.25 |
- |
|
| Isaly Samuel D |
Director |
– • • |
2008-05-13 |
4 |
B |
$2.40 |
$120,000 |
I/I |
50,000 |
3,050,000 |
2.25 |
- |
|
| Sheffery Michael B |
Director |
– • – |
2008-05-13 |
4 |
B |
$2.40 |
$120,000 |
I/I |
50,000 |
3,050,000 |
2.1 |
- |
|
| Van Bokkelen Gil |
Chmn & Chief Executive Officer |
• • – |
2007-12-12 |
4 |
B |
$5.00 |
$15,000 |
D/D |
3,000 |
105,032 |
2.81 |
- |
|
| Lehmann William Jr |
President & COO |
• – – |
2007-12-05 |
4 |
B |
$4.55 |
$4,550 |
D/D |
1,000 |
6,000 |
2.66 |
- |
|
| Lubin Daniel C |
10% Owner |
– – • |
2007-06-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,600,000 |
|
- |
|
| Milne George M Jr |
Director |
– • – |
2007-06-08 |
4 |
B |
$5.00 |
$8,000,000 |
I/I |
1,600,000 |
1,600,000 |
2.1 |
- |
|
| Milne George M Jr |
Director |
– • – |
2007-06-08 |
4 |
B |
$5.00 |
$50,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Sheffery Michael B |
Director |
– • – |
2007-06-08 |
4 |
B |
$5.00 |
$15,000,000 |
I/I |
3,000,000 |
3,000,000 |
2.1 |
- |
|
| Mulligan William C |
Director |
– • – |
2007-06-08 |
4 |
OE |
$0.01 |
$533,780 |
I/I |
306,354 |
488,646 |
|
- |
|
| Mulligan William C |
Director |
– • – |
2007-06-08 |
4 |
A |
$0.00 |
$0 |
I/I |
182,292 |
182,292 |
|
- |
|
| Loop Floyd D Md |
Director |
– • – |
2007-06-08 |
4 |
B |
$5.00 |
$8,000,000 |
I/I |
1,600,000 |
1,600,000 |
2.1 |
- |
|
| Orbimed Advisors Llc |
Director |
– • • |
2007-06-08 |
4 |
B |
$5.00 |
$15,000,000 |
I/I |
3,000,000 |
3,000,000 |
2.25 |
- |
|
| Campbell Laura K |
Vice President |
• – – |
2007-06-08 |
4 |
OE |
$0.01 |
$5,340 |
D/D |
3,063 |
3,063 |
|
- |
|
| Lehmann William Jr |
President |
• – – |
2007-06-08 |
4 |
B |
$5.00 |
$25,000 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Harrington John J |
Chief Scientific Officer |
• • – |
2007-06-08 |
4 |
OE |
$0.01 |
$106,755 |
D/D |
61,270 |
85,809 |
|
- |
|
436 Records found
|
|
Page 17 of 18 |
|
|
